openPR Logo
Press release

Universal $4 Bn Biosimulation Market | Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Advanced Chemistry Development, Certara USA, Simulation Plus, Schrodinger, Entelos, Physiomics PLC and Genedata AG

10-10-2018 10:55 AM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

Biosimulation Market

Biosimulation Market

A Research Study Titled, “Biosimulation Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the biosimulation market is projected to be around $4 billion by 2025.

Biosimulation is one such promising notion to drug discovery and development. It has been developed in order to avoid the hurdles in discovery and development of a new drug by traditional processes. It promises tremendous benefits saving both money and time and improves the predictability in early stage of the drug development. In biosimulation, the relationships between different biological elements are represented using differential equations utilizing simulation techniques to predict the behavior of the biological system and status of biological elements over time.

To request a sample copy or view summary of this report, click the link below: .

Competitive Analysis:

Some of the major players in biosimulation market include Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Inc., Advanced Chemistry Development, Inc., Certara USA, Inc., Simulation Plus, Inc., Schrodinger, Inc., Entelos, Inc., Physiomics PLC, and Genedata AG. The major strategies adopted by them to sustain the market competition are increasing collaborations and partnerships, patient medication, mergers and acquisitions, drug repositioning, modeling and simulations in pediatrics drug development and new product launches. For instance, in December 2016, Chemical Computing Group, Inc. launched new version of its protein structure database system - PSILO 2016.10 with easy access to protein structural information leading to quick discovery of drugs.

Industry Trend Analysis:

The biosimulation market is expected to be around $4 billion by 2025. This growth can be attributed to number of factors such as rise in incidence of chronic diseases such as diabetes, rise in aging population, high rate of drug resistance and failure. Moreover, unavailability of drugs to treat diseases such as AIDS and cancer is expected to further drive the global market. Further, rise in disposable income of the people and technological advancements such as use of micro assays for gene sequencing and analysis is set to contribute to the market growth. However, lack of standard method for biosimulation, lack of knowledge and unavailability of skilled professionals will restraint the market growth.

Product Outlook and Trend Analysis:

Software segment accounted for the largest share of the global biosimulation market in 2016, as software being crucial component of the process. The onset of high end in silico software is expected to open up new pathway for improved personalized medicines and enable better disease care management through improved drug designing and medication.

Application Outlook and Trend Analysis:

Drug development segment accounted for the largest share of the overall market in 2016 and is projected to witness robust growth during the forecast period, due to advancements in software for new drug development. The inclusion of high end software’s in drug designing will facilitate enhanced disease care through development of novel drugs especially in the field of personalized medicine.

End User Outlook and Trend Analysis:

Pharmaceutical and biotechnology companies segment occupied major share of the global market in 2016 owing to rise in adoption rate of high end in silico software’s for developing new and advanced drugs for various diseases such as cancer and diabetes.

Biosimulation market is segmented as follows:

Biosimulation Market, By Product:

In-house Services
Contract Services

Biosimulation Market, By Application:

Drug Discovery
Drug Development

Biosimulation Market, By End User:

Regulatory Authorities
Pharmaceutical & Biotechnology Companies
Academic Research Institutions

Get More Information of This Report: .

Market Opportunities:

There is a continuous rise in the demand for advanced software programs, which will provide ample growth opportunities for players operating in the global market. Technological advancements such as gene analysis, sequencing and coding, development of advanced mathematical model for biological assays and new methods of cell-based assays are expected to provide profitable market growth in coming years.

Biosimulation Market, By Region:

North America - U.S, Canada, Mexico

Europe - Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific

Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Regional Outlook and Trend Analysis:

North America dominated the global market in 2016. This can be attributed to number of factors such as developed healthcare infrastructure, technological innovations such as development of biochips and advanced cell assay methods, and increase in number of patent files for many drugs and search for new drug entity. Asia-Pacific market is expected to grow at highest rate over the forecast period, owing to various factors such as increase disposable income of people, rapid healthcare infrastructure development and increasing need for integrating IT software in healthcare systems.

Biosimulation Market, List of Tables:

Table 1.Global Biosimulation Market, By Product, 2016-2025 ($Million)
Table 2.Services Market, By Type, 2016-2025 ($Million)
Table 3.Services Market, By Region, 2016-2025 ($Million)
Table 4.In-house Services Market, By Region, 2016-2025 ($Million)

Biosimulation Market, List of Figures:

Figure 1.Global Biosimulation Market Share, By Product, 2016 & 2025
Figure 2.Global Biosimulation Market, By Application, 2016 ($Million)
Figure 3.Global Biosimulation Market, By End User, 2016 ($Million)

Discuss Our Expert Team: .

Key Findings of the Research Study:

• The biosimulation market will be majorly driven by rise in chronic disease incidence such as cancer and diabetes, increasing prevalence of geriatric population, high drug resistance by certain disease related pathogens and high drug failure rate.

• The services segment will exhibit favorable growth over the forecast period as more and more pharmaceutical companies are beginning to outsource their biosimulation processes in order to reduce costs and focus on core competencies.

• North America held a major share of the biosimulation market in 2016, commanding over more than half of the market. Due to presence of highly skilled professionals and research infrastructure along with presence of regulatory authorities ensuring patient safety, this market will show promising growth over the forecast period.

• Asia-Pacific market will exhibit the fastest growth rate during the forecast period due to rapidly improving healthcare infrastructure and growing Healthcare IT expenditure.


About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Universal $4 Bn Biosimulation Market | Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Advanced Chemistry Development, Certara USA, Simulation Plus, Schrodinger, Entelos, Physiomics PLC and Genedata AG here

News-ID: 1293052 • Views: 448

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases

More Releases for Biosimulation

Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The